Chimerix Analysis
| CMRXDelisted Stock | USD 8.54 0.01 0.12% |
Chimerix holds a debt-to-equity ratio of 0.095. With a high degree of financial leverage come high-interest payments, which usually reduce Chimerix's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Chimerix's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Chimerix's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Chimerix Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Chimerix's stakeholders.
For many companies, including Chimerix, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Chimerix, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Chimerix's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Chimerix's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Chimerix is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Chimerix to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Chimerix is said to be less leveraged. If creditors hold a majority of Chimerix's assets, the Company is said to be highly leveraged.
Chimerix is overvalued with Real Value of 6.25 and Hype Value of 8.54. The main objective of Chimerix delisted stock analysis is to determine its intrinsic value, which is an estimate of what Chimerix is worth, separate from its market price. There are two main types of Chimerix's stock analysis: fundamental analysis and technical analysis.
The Chimerix stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Chimerix is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Chimerix Stock trading window is adjusted to America/New York timezone.
Chimerix |
Chimerix Stock Analysis Notes
About 56.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.99. Chimerix had not issued any dividends in recent years. Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on Chimerix please contact Michael MBA at 919 806 1074 or go to https://www.chimerix.com.Chimerix Investment Alerts
| Chimerix is not yet fully synchronised with the market data | |
| Chimerix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 212 K. Net Loss for the year was (88.39 M) with loss before overhead, payroll, taxes, and interest of (74.36 M). | |
| Chimerix currently holds about 42.79 M in cash with (74.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Roughly 56.0% of the company shares are held by institutions such as insurance companies |
Chimerix Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 801.08 M.Chimerix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chimerix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chimerix Outstanding Bonds
Chimerix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chimerix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chimerix bonds can be classified according to their maturity, which is the date when Chimerix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Chimerix Predictive Daily Indicators
Chimerix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chimerix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Chimerix Debt to Cash Allocation
As Chimerix follows its natural business cycle, the capital allocation decisions will not magically go away. Chimerix's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Chimerix currently holds 458 K in liabilities with Debt to Equity (D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. Chimerix has a current ratio of 2.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Chimerix's use of debt, we should always consider it together with its cash and equity.Chimerix Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Chimerix's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Chimerix, which in turn will lower the firm's financial flexibility.Chimerix Corporate Bonds Issued
About Chimerix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Chimerix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chimerix shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Chimerix. By using and applying Chimerix Stock analysis, traders can create a robust methodology for identifying Chimerix entry and exit points for their positions.
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Chimerix to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Chimerix Stock
If you are still planning to invest in Chimerix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chimerix's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |